Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera

被引：9
|
作者：
Tiribelli, Mario [1 ]
Barraco, Daniela [1 ]
De Marchi, Federico [1 ]
Marin, Luciana [1 ]
Medeot, Marta [1 ]
Damiani, Daniela [1 ]
Fanin, Renato [1 ]
机构：
[1] Azienda Osped Univ Udine, Div Hematol & BMT, Dept Expt & Clin Med Sci, I-33100 Udine, Italy
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 05期
关键词：
ESSENTIAL THROMBOCYTHEMIA; RISK-FACTORS; CRITERIA;
D O I：
10.1007/s00277-014-2257-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：873 / 874
页数：2
相关论文
共 50 条
  • [1] Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera
    Mario Tiribelli
    Daniela Barraco
    Federico De Marchi
    Luciana Marin
    Marta Medeot
    Daniela Damiani
    Renato Fanin
    Annals of Hematology, 2015, 94 : 873 - 874
  • [2] Clinical complications and evolution of patients with essential thrombocythemia and polycythemia vera
    Burgaleta, M.
    Lopez Rubio, M.
    Helena, M.
    Carles, C.
    Beatriz, B.
    Teresa, T.
    Garcia Suarez, J.
    Calero, A.
    Masso, P.
    Martin, Y.
    Gil, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 525 - 525
  • [3] Incidence and risk factors for myelofibrotic transformation among 272 chinese patients with JAK2-mutated polycythemia vera
    Bai, Jie
    Ai, Limei
    Zhang, Lei
    Yang, Feng-Chun
    Zhou, Yuan
    Xue, Yanping
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (12) : 1116 - 1121
  • [4] THROMBOEMBOLISM PREDICTIVE FACTORS IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
    Bellora, A.
    Tamiazzo, S.
    Primon, V.
    Pini, M.
    Corsetti, M. T.
    Cornaglia, E.
    Demichelis, M.
    Santi, R.
    Contino, L.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 410 - 410
  • [5] THROMBOEMBOLISM PREDICTIVE FACTORS IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTOPENIA
    Ionita, M. I.
    Ionita, I.
    Pacurar, R.
    Nicola, D. E.
    Ionita, C. O.
    Todorescu, V.
    Ionita, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 606 - 606
  • [6] Basophilia in Polycythemia Vera Is Associated with an Increased Risk of Leukemic and Myelofibrotic Transformation
    Siraga, Mahlet
    Abdelmagid, Maymona
    Iftikhar, Moazah
    Rana, Masooma S.
    Begna, Kebede
    Reichard, Kaaren K.
    He, Rong
    Mendoza, Cinthya Zepeda
    Go, Ronald S.
    Pardanani, Animesh D.
    Gangat, Naseema
    Tefferi, Ayalew
    BLOOD, 2024, 144 : 6625 - 6626
  • [7] Ruxolitinib: evolution or revolution in treatment of patients with polycythemia vera?
    Beauverd, Yan
    McLornan, Donal P.
    Radia, Deepti H.
    Harrison, Claire N.
    FUTURE ONCOLOGY, 2016, 12 (06) : 739 - 749
  • [8] MUTATIONS IN THE RNA SPLICING MACHINERY GENES IN MYELOFIBROTIC TRANSFORMATION OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Bellosillo, B.
    Martinez-Aviles, L.
    Alvarez-Larran, A.
    Camacho, L.
    Pairet, S.
    Fernandez-Rodriguez, C.
    Angona, A.
    Serrano, S.
    Besses, Carlos
    HAEMATOLOGICA, 2013, 98 : 115 - 115
  • [9] ASSESSMENT OF FACTORS OF CARDIOVASCULAR RISK IN PATIENTS WITH POLYCYTHEMIA VERA
    Segura Diaz, A.
    Yus Cebrian, M. F.
    Recasens Flores, V
    Parra Salinas, I
    Calvo Villas, J. M.
    Caballero Navarro, G.
    Rubio Martinez, A.
    Delgado Beltran, P.
    HAEMATOLOGICA, 2015, 100 : 282 - 282
  • [10] HOST FACTORS IN POLYCYTHEMIA VERA
    DAMON, A
    HOLUB, DA
    ANNALS OF INTERNAL MEDICINE, 1958, 49 (01) : 43 - 60
12345